E2 ModeratePreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients.
Nijs, Jo, Nicolson, Garth L, De Becker, Pascale et al. · FEMS immunology and medical microbiology · 2002 · DOI
Quick Summary
This study looked for four types of bacteria called Mycoplasma in the blood of 261 ME/CFS patients in Europe and compared them to 36 healthy people. The researchers found that about 69% of ME/CFS patients had at least one type of Mycoplasma bacteria, compared to only 6% of healthy controls. The most common type found was M. hominis, followed by M. pneumoniae and M. fermentans.
Why It Matters
This study provides evidence that Mycoplasma infections occur at much higher rates in ME/CFS patients than in healthy people, suggesting a possible infectious component to the disease. Understanding whether these infections contribute to ME/CFS symptoms or disease progression could open new diagnostic and treatment approaches for European patients.
Observed Findings
- 68.6% (179 of 261) of European CFS patients had at least one Mycoplasma species detected, compared to 5.6% (2 of 36) healthy controls
- M. hominis was the most prevalent species in European patients (36.8%), differing from American cohorts where M. pneumoniae was most common
- 17.2% of infected CFS patients (45 patients) had multiple concurrent Mycoplasma infections
- M. penetrans was not detected in any patient or control sample
- The prevalence difference between CFS patients and controls was statistically significant (P<0.001)
Inferred Conclusions
- Mycoplasma infections are significantly more prevalent in European ME/CFS patients than in the general healthy population
- Geographic differences exist in the pattern of Mycoplasma species distribution between European and American ME/CFS cohorts
- Multiple concurrent Mycoplasma infections occur in a subset of ME/CFS patients, suggesting potential cumulative effects
Remaining Questions
- Do Mycoplasma infections precede ME/CFS symptom onset, or are they acquired secondarily due to immune dysfunction?
- Does the presence or burden of Mycoplasma infection correlate with symptom severity or specific ME/CFS phenotypes?
What This Study Does Not Prove
This study does not prove that Mycoplasma infections cause ME/CFS, only that they are more common in ME/CFS patients. The cross-sectional design means it cannot determine whether infections preceded illness onset or resulted from immunosuppression caused by ME/CFS. It also does not establish whether treating these infections would improve ME/CFS symptoms.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →